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Neurocysticercosis (NCC) is caused by the larval form of the pork tapeworm Taenia solium and is the
commonest parasitic infestation of the central nervous system. NCC is usually managed medically but in
some instances surgery is required. Magnetic resonance imaging (MRI) and computed tomography (CT)
are often able to provide the diagnosis of NCC in most patients with intraventricular and parenchymal
cysts but in patients with hydrocephalus without any cysts, the diagnosis is conﬁrmed by the presence of
cysticercal antibodies in the serum. Surgery is usually recommended for intraventricular cysts, hydro-
cephalus, large cisternal cysts, large parenchymal cysts and when the diagnosis is not certain on imaging
studies. For intraventricular cysts, endoscopic surgery is the procedure of choice as it is minimally
invasive. For incompletely excised cysts and cysts or granulomas in locations such as the spinal cord,
medical treatment with steroids and albendazole is recommended. Hydrocephalus is treated with
a ventriculo-peritoneal shunt but shunts in these patients suffer from frequent obstructions and require
multiple revisions. The outcome for patients with intraventricular and parenchymal cysts is usually good
but for those with hydrocephalus associated with cisternal or racemose cysts and with cysticercotic
meningitis, the mortality is high.
 2009 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
The larval form (cysticercus) of the cestode Taenia solium or the
pork tapeworm causes cysticercosis. Man is an accidental inter-
mediate host who becomes infected by consuming eggs in the
gravid proglottids of the adult tapeworm shed in the stools of
a carrier of the worm. The natural life cycle has the pig as the
intermediate host, man being the deﬁnitive host. Cysticercosis is
endemic in several under-developed regions of the world except
the predominantly Muslim countries of Saharan Africa and Middle
East.1 Larvae of T. solium lodge selectively in certain organs of the
body such as the subcutaneous tissues, eyes, muscles and the brain.
When they infect the brain it leads to the condition referred to as
Neurocysticercosis (NCC).
NCC is the commonest parasitic infestation of the brain and it is
estimated that nearly 50 million people worldwide suffer from this
disease.2 Approximately, 50,000 individuals with NCC die each year
due to the disease. Seizures or epilepsy is the commonest mani-
festation of NCC affecting nearly 80% of patients with NCC. A recent
study from south India based on a survey of over 50,000 people
reported that NCC was the cause of a nearly a third of active
epilepsy in the community.3 Calculations on the basis of this ﬁgureciates Ltd. Published by Elsevier Ltwould suggest that, in India, there are one million patients with
active epilepsy due to NCC.
The mainstay of therapy of NCC is medical and symptomatic.
Cysticidal drugs such as praziquantel and albendazole are also used
in the treatment of NCC. Surgery is reserved for selected patients
with NCC and plays a minor role in the management of the disease.
2. Pathology of NCC
Cysticercus cysts can reside in different intracranial and intra-
spinal compartments. Most often they reach the parenchyma of the
brain through the blood stream. Once they reach the brain, the
larva undergoes degeneration at varying rates ranging from a few
weeks to several years. The larva lodged in the parenchyma goes
through four stages namely, (i) vesicular; (ii) colloidal; (iii) gran-
ular-nodular; and (iv) calciﬁc stages.4 Usually the vesicular or live
stage does not cause symptoms. As the process of degeneration
begins, the host mounts an inﬂammatory response to the cyst and
this leads to symptoms such as seizures. The other three degener-
ating stages of the parenchymal cyst can all cause seizures and the
colloidal stage can occasionally produce symptoms and signs of
a mass lesion producing raised intracranial pressure (ICP) with or
without focal neurological symptoms and signs. If the number of
cysts in the brain is numerous, then their degeneration can lead to
severe edema and severely raised ICP causing headache, vomiting,
altered sensorium and even death. This form of NCC is termedd. All rights reserved.
Fig. 1. A typical solitary cysticercus granuloma (SCG) which is the commonest mani-
festation of neurocysticercosis in Indian patients.
Fig. 2. T1 weighted MR image in a patient with a third ventricular cysticercus cyst.
Note the presence of a hyperintense dot in the inferior part of the cyst conﬁrming the
diagnosis of a cysticercus cyst. A cysticercus cyst was excised from the third ventricle
through a right frontal burr hole using endoscopic techniques.
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NCC in Latin America and other endemic countries harbour several
cysts in their brain, nearly two-thirds of the patients in India have
only one degenerating cyst – the solitary cysticercus granuloma
(SCG) (Fig. 1).5 SCG is the commonest cause of focal seizures in
Indian patients. It is the cause of focal seizures (with or without
secondary generalization) in nearly 50% of patients presenting to
some Indian hospitals.6
Besides the parenchyma, the cysts can also enter the ventricular
system where they may cause hydrocephalus by blocking the
circulation of cerebrospinal ﬂuid (CSF). Finally, the cysts can reside
in the subarachnoid spaces at the base of the brain or in the sylvian
ﬁssures. In this location, the cysts lose their scolices and creep along
the subarachnoid spaces. This form of the cyst is termed a ‘‘race-
mose cysticercus cyst’’. The symptoms associated with subarach-
noid cysts are due to the severe inﬂammation of the vessels in the
subarachnoid spaces which cause infarcts of the brain stem and the
basal ganglia.
NCC rarely affects the spinal cord. Intramedullary cysticercus
granulomas are occasionally known to cause paraparesis.
3. Indications for surgery
A group of international experts in cysticercosis published a
consensus statement regarding the management of NCC.7 They
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In addition to these conditions, the following situations may
need a neurosurgical intervention in patients with NCC.81. Large parenchymal colloidal cyst or subarachnoid racemose
cyst causing mass effect;
2. To conﬁrm the diagnosis in case of an atypical SCG; and
3. Surgery for intractable epilepsy associated with NCC.4. Surgery for intraventricular cysts
Patients with intraventricular cysts usually present with
persistent or intermittent features of raised ICP. Computed
tomography (CT) or magnetic resonance (MR) scan will usually
show hydrocephalus as the cause of the raised ICP. Since the cyst
within the ventricle has the same density or intensity as the
surrounding CSF, it is often difﬁcult to identify the cyst or cysts.
Occasionally, the scolex can be seen as a hyperintense dot within
the cyst this being diagnostic of a cysticercal cyst (Fig. 2). A cys-
ticercal cyst in the anterior third ventricle canmimic a colloid cyst.9
Other differential diagnosis includes choroid plexus or ependymal
cysts. Special MR sequences such as 3D CISS (constructive inter-
ference steady state) or FLAIRmay reveal the cysts.10 However, even
with the special MR sequences, the cyst/s might not be visualised
and in cases where an intraventricular cyst is being strongly sus-
pected, a CT ventriculogram will clearly outline the cyst or cysts as
ﬁlling defects in the contrast ﬁlled ventricles (Fig. 3).11 The cysts can
be present in the lateral, third or fourth ventricles, the last location
being the commonest.12 These cysts are free ﬂoating and can move
about the ventricles depending on the position of the head. As the
cyst can migrate from one ventricle to another it is advisable to
perform an MR or CT just before the planned surgery in order to
avoid an inappropriate procedure or approach.13 A contrast study
should be done to determine the presence or absence of associated
inﬂammation. The inﬂamed cyst wall will enhance and in such
patients it might be prudent to proceed with a shunt and treat the
cyst with medical therapy. Cysts with inﬂamed walls are known to
be densely adherent to the surrounding ependyma and choroid
plexus and attempts at excision might lead to neurological
morbidity and a poor outcome.14
Fig. 3. A CT ventriculogram in a patient with suspected lateral ventricular cysticercus
cyst. Contrast was injected into the right frontal horn. Note the ﬁlling defect in the
right lateral ventricle caused by the large cysticercal cyst. Through a right frontal burr
hole using endoscopic techniques, this large cyst was excised and the patient made an
uneventful recovery.
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craniotomy and standard approaches to the ventricular system
have been used for several years to excise intraventricular cys-
ticercal cysts, 12,15–17 presently, the surgical procedure of choice is
the minimally invasive endoscopic excision of the cysts especially
for lateral and third ventricular cysts.11,12,18,19 Endoscopic surgery
avoids the complications of a large craniotomy and reduces
manipulation of the brain. A rigid scope can be used for excision of
cysts in the lateral and anterior third ventricles. However, a ﬂexible
scope may be better suited for cysts in the posterior third ventricle
or aqueduct region. A single burr hole placed in the pre-coronal
region on the appropriate side will usually enable the surgeon to
access cysts in the lateral and third ventricle. The surgeon should
not attempt to deliver the cyst through the working channel of the
scope as this will lead to the loss of the cyst in the ventricle. Once
the cyst is grasped with a grasping forceps, it should be brought to
the distal end of the scope and the entire scope assembly
(including the sheath, scope and grasping forceps) with the cyst
wall should be delivered through the burr hole.
For most neurosurgeons, a suboccipital craniectomy and exci-
sion of fourth ventricular cysts is a straightforward although a
slightly more invasive procedure. Endoscopic surgery for cysts in
the fourth ventricle is more demanding and should not be under-
taken by novices.18 Careful study of the MR images can provide
guidance about the appropriate route to the cyst. An endoscopic
approach through a pre-coronal burr hole using a rigid scope could
be used for cysts that are located in the upper fourth ventricle and
the aqueduct. Such a cyst can be seen through the aqueduct and its
wall can be grasped and the cyst excised as in the case of third
ventricular or lateral ventricular cyst. A ﬂexible endoscope is
needed for the excision of cysts in the fourth ventricle presenting at
the foramen of Magendie. A small midline incision is made in the
suboccipital region to expose the atlanto-occipital membrane and
after opening the dura the scope is introduced into the cisterna
magna and then negotiated between the tonsils to the foramen of
Magendie where the cyst can be visualised.18 If there are denseadhesions occluding the foramen of Magendie then the procedure
might have to be abandoned.
Occasionally, the cysts are densely adherent to the surrounding
ependyma and may not deliver easily. In this case, the procedure
might have to be terminated and a shunt would be needed to treat
the hydrocephalus.12,14 Such cysts can be treated with cysticidal
drugs such as praziquantel and albendazole.20 The excision of
lateral and third ventricular cysts can be combined with other
procedures such as septostomy to create a communication between
both the lateral ventricles and a third ventriculostomy to relieve
hydrocephalus due to an obstruction in the region of the
aqueduct.14
One of the frequently raised concerns is the consequence of the
rupture of a ventricular cysticercal cyst while excising it. Madrazo
et al.21 considered the rupture of the cysts to be associated with
serious consequences and devised a pipette to perform an atrau-
matic removal of the cysts.22 However, most surgeons experienced
with the excision of intraventricular or cisternal cysticercus cysts
have not reported any untoward incidents associated with intra-
operative rupture of cysts.14,16 Unlike a parenchymal hydatid cyst,
rupture of an intraventricular cysticercus cyst does not lead to
either dissemination of the disease or an anaphylactic reaction.
Usually patients with a single intraventricular cyst do not need any
further therapy after excision. However, those suspected to have
more cysts should be treated with oral albendazole (15 mg/kg body
weight in two daily divided doses) for 2 weeks. A course of steroids
(prednisolone or dexamethasone) can be given for the ﬁrst 5–7
days of albendazole therapy.
The hydrocephalus usually resolves following excision of the
intraventricular cysts and shunts can be avoided in over 70% of
cases.11,14 However, in some cases, the ependymitis resulting from
degeneration of the cysts either within the ventricles or in the
subarachnoid spaces might lead to persistence of the hydroceph-
alus necessitating the placement of a shunt.
Although medical therapy of intraventricular cysts has been
proposed,20 the effect of the therapy takes several days to weeks
and during this period some patients might deteriorate acutely.
Sudden death with intra-third ventricular cysts has been
reported.12
5. Surgery for hydrocephalus
Hydrocephalus associated with NCC occurs in the presence of
intraventricular cysts, racemose cysts in the basal subarachnoid
cisterns and due to obstruction at the outlet of the fourth ventricle
due to basal cysticercotic meningitis and ﬁbrosis or ependymitis
even in the absence of cysts. As mentioned above, hydrocephalus
associated with intraventricular cysts usually does not require
shunt surgery after excision of the cyst or cysts. A ventriculo-peri-
toneal (VP) shunt is recommended for hydrocephalus associated
with other forms of NCC. As for any inﬂammatory process causing
hydrocephalus, NCC associated hydrocephalus is associated with
the need for repeated shunt revisions.23,24 This complication may
be related to high protein or cell content in the CSF and even due to
obstruction of the shunt by small cysts or inﬂammatory exudates.
Shunts have also been known to be the cause of migration of fourth
ventricular cysts into the third or lateral ventricles due to a siphon
effect.14 Sotelo et al.25 have devised a new shunt system which
reduced the frequency of shunt revisions from 45% to 30%.
However, this system does not provide an ideal solution to the
problem of frequent shunt obstruction as in some cases it resulted
in the conversion of symptoms of raised ICP to those of normal
pressure hydrocephalus.26 As of now, a standard shunt system is
suitable for use in patients with hydrocephalus due to NCC. Long-
term steroid therapy with daily oral prednisone at a dose of 50 mg
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rate of shunt dysfunction from 60% to 13%.26 However, prophylaxis
for tuberculosis with isoniazid is recommended as prolonged
steroid therapy can predispose a patient to tuberculous infection. 27
6. Spinal NCC
Intramedullary and extramedullary cysticercal cysts in the
spinal cord are rare causes of spinal cord compression, the former
being more commonly reported.28 Surgery is usually indicated as
the diagnosis is uncertain. However, if there is evidence of cys-
ticercal infection from a positive enzyme linked immunotransfer
blot (EITB) for cysticercal antibodies in the serum, then surgery can
be avoided. Once a diagnosis of intramedullary NCC is made, the
patient might be prescribed steroid therapy alone for a maximum
of two weeks or albendazole with steroid therapy for two weeks.29
7. Surgery for large parenchymal and racemose cysts
Occasionally patients might present acutely with large paren-
chymal cysts (usually in the colloidal stage of evolution) causing
focal neurological deﬁcits and raised ICP (Fig. 4).16,24,30,31 In such
situations, surgery might be required on an emergent basis to
reverse the deﬁcits and reduce the raised ICP. Often, the diagnosis
of a cysticercal cyst is also not secured without a biopsy as the
imaging features mimic those of an abscess or a metastatic lesion.
Craniotomy and excision of the cyst often lead to a good outcome.
Similarly, large cysts in the basal subarachnoid spaces such as
the suprasellar cistern or cerebellopontine cistern can present
with pressure effects on the adjacent neurological structures.32 In
several instances the diagnosis of racemose cysticercosis is not
evident on routine MR imaging. Diffusion weighted imaging (DWI)
is necessary to distinguish these cysts from the more common
epidermoid cysts. These lesions can be excised through an appro-
priately placed craniotomy. The cysts are often easily delivered but
in some cases parts of the cysts densely adherent to neurovascular
structures in the vicinity might have to be left in situ.Fig. 4. A large right temporal ring enhancing mass on the CT of a patient presenting
with features of raised intracranial pressure. The mass was excised and the histology
revealed a cysticercal cyst with inﬂammation. This is a colloidal cyst.8. Surgery for atypical SCG
Surgery is nearly never needed for typical SCG presenting with
seizures.33 However, in some patients SCG can present with atyp-
ical symptoms such as severe headache or have atypical radiolog-
ical features. In 7% of patients with SCG, the granuloma might
enlarge (referred to as ‘‘enlarging SCG’’) and a differential diagnosis
of other pathologies such as tuberculoma or an abscess might
necessitate a histological diagnosis.34 Finally, SCG in locations such
as the brain stem might require histological veriﬁcation.35 Stereo-
tactic techniques are often required to excise or biopsy these small
lesions located in eloquent regions of the brain.35,36 However, if
there is a high index of suspicion, then serum should be tested for
cysticercal antibodies and if found positive, then either symptom-
atic therapy or treatment with albendazole will avoid a surgical
exploration.
9. Surgery for intractable epilepsy associated with NCC
Occasionally, surgery is required to control intractable epilepsy
associated with NCC. The cause of the epilepsy is either an
epileptogenic scar around a cortical cysticercal lesion such as
a granuloma or mesial temporal sclerosis (MTS) associated with
NCC. It has been postulated that NCC could cause MTS by various
mechanisms such as kindling, seizures due to NCC causing MTS and
due to inﬂammation spreading from an adjacent degenerating
cysticercal cyst.37,38 In patients with intractable epilepsy associated
with NCC the work up and subsequent surgery is similar to that
performed for intractable epilepsy in general.
10. Medical therapy
Medical therapy for NCC is not the focus of this article and hence
it will be dealt with brieﬂy. In most patients symptomatic therapy
alone is indicated. This usually consists of analgesics for headache,
anti-epileptic drugs (AEDs) for seizures and steroids to treat raised
ICP.
AEDs may be stopped soon after the resolution of a SCG with
a low risk of seizure recurrence.39 However, in patients with calciﬁc
residues of the granuloma or multiple granulomas, AEDs have to be
continued for several years due to a high risk of recurrent seizures.
Steroids are usually used for brief periods of one or two weeks.
Prednisolone (1 mg/kg body weight) or dexamethasone (8–16 mg/
day in divided doses) is generally recommended. Steroids are used
in patients who present with a ﬂurry of seizures and in those with
cysticercotic encephalitis. Steroids are also used in the ﬁrst week of
a cysticidal drug regime.
Cysticidal drugs (praziquantel and albendazole) are known to
destroy live larval cysts whether in the parenchyma, ventricles or
the subarachnoid spaces and possibly hasten the resolution of
granulomas. However, therapy with cysticidal drugs is controver-
sial and there is no consensus on the indications for their use.
Similarly, there is no agreement or evidence for the ideal duration
of therapy with these drugs. Albendazole is preferred over prazi-
quantel for its lower cost and side effects. A dose of 15 mg/kg body
weight in 2 divided doses for 15 days is the most commonly used
regime.
There are some types of NCC for which cysticidal drug therapy is
contraindicated. Patients with cysticercotic encephalitis may have
a fatal outcome if treated with cysticidal drugs due to the increase
in edema around the degenerating cysts. Cysticidal drugs by
causing acute degeneration of the cysts can lead to an exacerbation
of the already elevated ICP causing the death of the patient. Such
patients are ideally managed only with steroids and anti-edema
measures such as mannitol and glycerol.
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Complications of surgery for NCC are similar to those for any
intracranial pathology. However, endoscopic surgery is generally safe.
The major complications for endoscopic surgery include intraventric-
ular hemorrhage, forniceal damage, CSF leak, seizures and menin-
gitis.11,12,18,19 These complications occur in less than 5% of patients.
The outcome following surgery for NCC depends on the form of
the disease for which the surgery was done. For intraventricular
cysts, large parenchymal cysts, large racemose cysts causing mass
effect and for biopsy or excision of atypical SCG, the outcome is
generally excellent with over 95% of patients making an uneventful
recovery. Couldwell et al.40 found that 75% of patients with NCC
who underwent surgery had improved at a follow up of 3 years.
However, shunt surgery for hydrocephalus caused by cysticercotic
meningitis is complicated by frequent shunt revisions for blockages
or infection in as many as 68% of patients and carries a mortality of
50% on long-term follow up.24 Mortality is particularly high in
patients with basal racemose cysticercosis.
12. Prevention of cysticercosis
Cysticercosis is a disease associated with poverty and poor
hygiene, lack of sanitation and an unregulated pork industry. It is an
eradicable disease as it has a well-characterized life cycle in which
humans are the only deﬁnitive hosts. The best prevention strategy
would involve the universal use of latrines by the population. Since
that is unlikely to be achieved in a short period of time in several
developingcountries, other short-termmeasureshavebeentriedand
found to reduce the disease burden. The possible strategies to control
cysticercosis include health education emphasizing the need for
hygienic practices such as hand washing after defecation and before
eating, mass chemotherapy for taeniasis and vaccination of pigs.
13. Conclusions
Surgery is infrequently required in the management of patients
with NCC. The commonest indication is for the excision of intra-
ventricular cysts. Endoscopic surgery is the procedure of choice for
excision of intraventricular cysticercal cysts as it is minimally
invasive. Shunt surgery for hydrocephalus associated with cys-
ticercotic meningitis is the next common indication for surgery.
Whereas patients with intraventricular cysts have a good prognosis
those with hydrocephalus have a poor outcome with the need for
multiple shunt revisions and a high morbidity and mortality.
Miscellaneous indications for surgery in patients with NCC include
large parenchymal cysts, spinal cord cysts, atypical SCG and surgery
for intractable epilepsy. Eradication of the disease is possible but
socio-economic factors prevent achievement of this goal in the near
future in several under-developed regions of the world.Conﬂict of interest
The author has declared no conﬂict of interest.
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